Literature DB >> 9769479

The NF-kappaB and IkappaB system in injured arteries.

V Lindner1.   

Abstract

Activation of endothelial cells and dedifferentiation of smooth muscle cells (SMC) are events in the development of vascular disease. The NF-kappaB transcription factor family and its inhibitory proteins (IkappaB) have been implicated in regulating the expression of genes associated with the concomitant inflammatory response. To determine the role of the NF-kappaB/IkappaB system in vivo, the present study used the balloon catheter injury model in the rat carotid artery. Immunoblotting revealed that higher levels of the NF-kappaB family members p50, p52, p65, c-Rel, and RelB were expressed in injured arteries during lesion formation compared to normal vessels. Using electromobility shift assays, low levels of constitutively activated NF-kappaB were seen in normal carotid arteries and an induction occurred during times of rapid SMC proliferation. Furthermore, immediately after injury, the levels of the inhibitor proteins IkappaB alpha, IkappaB beta, and p105 were dramatically reduced. Consistent with the activation of NF-kappaB, vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemotactic protein-1 (MCP-1) were induced in SMC and endothelial cells as early as 4 h after injury and this was accompanied by adhesion of monocytes/macrophages. SMC forming a pseudoendothelium in chronically denuded vessels continued to express high levels of VCAM-1 and MCP-1, thus perpetuating the inflammatory response. These findings link the activation of NF-kappaB to the inflammatory response and to intimal lesion formation following vascular injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769479     DOI: 10.1159/000028039

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  12 in total

Review 1.  Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury.

Authors:  Neeta Adhikari; Nathan Charles; Ute Lehmann; Jennifer L Hall
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

2.  Characterization of the in vitro anti-inflammatory activity of AL-5898 and related benzopyranyl esters and amides.

Authors:  Karen C David; Milton T Brady; Lori K Weimer; Mark R Hellberg; Jon C Nixon; Gustav Graff
Journal:  Inflammation       Date:  2003-02       Impact factor: 4.092

3.  Copper chelation represses the vascular response to injury.

Authors:  Lazar Mandinov; Anna Mandinova; Stanimir Kyurkchiev; Dobroslav Kyurkchiev; Ivan Kehayov; Vihren Kolev; Raffaella Soldi; Cinzia Bagala; Ebo D de Muinck; Volkhard Lindner; Mark J Post; Michael Simons; Stephen Bellum; Igor Prudovsky; Thomas Maciag
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

4.  Nuclear factor-kappaB regulates estrogen receptor-alpha transcription in the human heart.

Authors:  Shokoufeh Mahmoodzadeh; Stephan Fritschka; Elke Dworatzek; Thi H Pham; Eva Becher; Arne Kuehne; Mercy M Davidson; Vera Regitz-Zagrosek
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

5.  Targeting activation of specific NF-κB subunits prevents stress-dependent atherothrombotic gene expression.

Authors:  Zdenka Djuric; Muhammed Kashif; Thomas Fleming; Sajjad Muhammad; David Piel; Rüdiger von Bauer; Florian Bea; Stephan Herzig; Martin Zeier; Marina Pizzi; Berend Isermann; Markus Hecker; Markus Schwaninger; Angelika Bierhaus; Peter P Nawroth
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

6.  Cordycepin inhibits vascular adhesion molecule expression in TNF-α-stimulated vascular muscle cells.

Authors:  Li-Jie Yan; Hai-Tao Yang; Hong-Yan Duan; Jin-Tao Wu; Peng Qian; Xian-Wei Fan; Shanling Wang
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

7.  Estrogen modulates NFκB signaling by enhancing IκBα levels and blocking p65 binding at the promoters of inflammatory genes via estrogen receptor-β.

Authors:  Dongqi Xing; Suzanne Oparil; Hao Yu; Kaizheng Gong; Wenguang Feng; Jonathan Black; Yiu-Fai Chen; Susan Nozell
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

8.  Different effects of antisense RelA p65 and NF-kappaB1 p50 oligonucleotides on the nuclear factor-kappaB mediated expression of ICAM-1 in human coronary endothelial and smooth muscle cells.

Authors:  R Voisard; N Huber; R Baur; M Susa; O Ickrath; A Both; W Koenig; V Hombach
Journal:  BMC Mol Biol       Date:  2001-08-08       Impact factor: 2.946

9.  Alterations in the expression of the NF-κB family member RelB as a novel marker of cardiovascular outcomes during acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Laura Labonté; Patrick Coulombe; Michela Zago; Jean Bourbeau; Carolyn J Baglole
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

10.  Smooth muscle-selective inhibition of nuclear factor-κB attenuates smooth muscle phenotypic switching and neointima formation following vascular injury.

Authors:  Tadashi Yoshida; Maho Yamashita; Chihiro Horimai; Matsuhiko Hayashi
Journal:  J Am Heart Assoc       Date:  2013-05-23       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.